Peptide Guides
Important
TB-500 is not an approved medicine in any country. It holds no licence from the MHRA in the United Kingdom, the EMA in Europe, or the FDA in the United States. This guide explains legal status and anti-doping rules. It is not medical or legal advice, and nothing within it constitutes a recommendation to use TB-500. Products supplied through this site are intended for laboratory research use only.
Quick answer
- In the UK, TB-500 is not a controlled substance. It is supplied as a laboratory research chemical, and classification depends on how a product is presented and intended to be used.
- No TB-500 product holds a UK marketing authorisation as a medicine. Whether a product falls within medicines regulation depends on its presentation, intended use and pharmacological properties; a research-use label does not settle that by itself.
- In sport it is prohibited at all times: the 2026 WADA Prohibited List names "Thymosin-ß4 and its derivatives e.g. TB-500" under S2.3.
- Anti-doping laboratories have published validated detection methods for it.
| Status of TB-500 | |
|---|---|
| Status checked | 28 September 2026 |
| UK controlled substance | No |
| MHRA medicines licence | None; not licensed for human use anywhere |
| WADA category | S2.3 Growth Factors and Growth Factor Modulators, named as an example |
| Prohibited in sport | At all times, in and out of competition |
We review this page whenever WADA publishes a new Prohibited List and when the UK regulatory position changes.
Is TB-500 Legal in the UK?
TB-500 occupies the same UK position as most research peptides. It is not listed under the Misuse of Drugs Act, so possessing it is not a drugs offence. No product containing TB-500 or thymosin beta-4 holds a marketing authorisation from the MHRA, so none can be sold as a licensed medicine or presented as treating any condition. That does not by itself decide how every TB-500 product is regulated. The MHRA assesses whether a product is a medicinal product case by case. It looks at the claims made for the product, its pharmacological properties, its intended purpose, and how it is presented to the public, including labelling, websites, advertising and customer reviews.5 A "research use only" label is not a legal safe harbour. What research use only means explains the framework in full.
Separately, in the United States, the FDA reviewed TB-500 in 2026 and proposed that it not be added to the list of substances pharmacies there can compound. That process has no bearing on UK status. The safety gap behind it, the absence of human data for the fragment, is covered in TB-500 side effects.
How Is TB-500 Supplied for Laboratory Research in the UK?
In the UK, TB-500 reaches laboratories as a research chemical rather than through any pharmacy or medical route. Where a product is genuinely supplied for laboratory research rather than as a medicine, it does not go through the authorisation and batch-release checks that licensed medicines do. Batch-specific analytical testing is therefore what verifies identity and purity. For this compound in particular, an identity test matters, because products under the TB-500 name may contain either the short copied section or the full natural peptide.
TB-500 and the 2026 WADA Prohibited List
The 2026 WADA Prohibited List names the compound directly. Under category S2.3, Growth Factors and Growth Factor Modulators, the list prohibits "Thymosin-ß4 and its derivatives e.g. TB-500", at all times, in and out of competition, as a non-specified substance.1
The listing covers both full-length thymosin beta-4 and the TB-500 fragment. Everywhere else on this site the difference between those two molecules matters. Under anti-doping rules it does not: both are prohibited. The two compounds also sit in different parts of the list. BPC-157 is prohibited under S0 as a non-approved substance, while TB-500 is prohibited under S2.3 as a growth factor; whether BPC-157 is banned in sport covers the BPC-157 side. The practical result is the same. Either compound in a sample produces an anti-doping rule violation.
UK Anti-Doping enforces the WADA code and list for UK athletes, so this position applies unchanged in the United Kingdom.2
Can anti-doping tests detect TB-500?
Yes. Detection is where TB-500 entered the scientific literature in the first place. Racing chemists published the first method for finding the fragment and its breakdown products in horses in 2012, after confirming it in samples from dosed animals.3 For human sport, doping-control laboratories have published screening methods covering WADA-listed small peptides including TB-500, with detection limits in the tens to hundreds of picograms per millilitre of urine.4 An athlete should assume a doping control sample can be tested for it.
No published human study defines how long TB-500 remains detectable after exposure, so no detection window can be stated. What is published is capability, and the capability is sensitive.
What Strict Liability Means for Athletes
Anti-doping operates on strict liability for presence violations: the athlete is responsible for what is found in their sample regardless of intent. Research peptides add contamination risk to that picture, since an unregulated vial can contain substances its label never mentions. A certificate of analysis provides evidence about a tested sample; it cannot make a prohibited substance permissible.
Banned in Sport vs Illegal in the UK
These are different systems. In the UK, TB-500 is not a controlled drug and possession is generally not an offence. Anti-doping rules are contractual rules of sport that sit on top of the general law, so a substance can be lawful to possess and still produce an anti-doping rule violation when it appears in a sample. Athletes and support personnel should check the current WADA Prohibited List and Global DRO directly, and treat this page as a summary rather than the authority.
Common questions
Is TB-500 legal in the UK?
It is not a controlled drug, so possession is not an offence, and it has no medicines licence anywhere, so nothing containing it can be sold as a medicine. Research products may fall outside medicines regulation, with classification depending on a product's overall presentation and intended use.
Is TB-500 banned by WADA?
Yes, at all times. The 2026 Prohibited List names it explicitly under S2.3 as a derivative of thymosin beta-4.1
Does TB-500 show up on a drug test?
Sport anti-doping tests are the relevant context, and laboratories have published validated methods for TB-500 in urine at picogram-level sensitivity.4 TB-500 is not part of typical workplace drug-screening panels, which target common drugs of abuse, though panels vary.
Can you buy TB-500 in the UK?
Research suppliers offer it as a laboratory chemical. No high-street or pharmacy route exists, because no licensed product exists.
TB-500 Research Specification
The current TB-500 batch and certificate of analysis covers freeze-dried (lyophilised) powder, purity-tested by HPLC with identity confirmed by mass spectrometry and a dated certificate of analysis per batch. For transparency, we sell research peptides and we market nothing to athletes.
Supplied for laboratory research use only. Not for human consumption.
References
- World Anti-Doping Agency. Prohibited List 2026, effective 1 January 2026, category S2.3: Growth Factors and Growth Factor Modulators ("Thymosin-ß4 and its derivatives e.g. TB-500"). WADA
- UK Anti-Doping. The Prohibited List and what is banned in sport. UKAD
- Ho ENM, Kwok WH, Lau MY, et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography-mass spectrometry. J Chromatogr A. 2012;1265:57-69. DOI
- Thomas A, Görgens C, Guddat S, et al. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. J Sep Sci. 2015;39(2):333-41. DOI
- Medicines and Healthcare products Regulatory Agency. Borderline products: how to tell if your product is a medicine. Updated 2 July 2026. MHRA guidance